Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisporivir + Peg-IFN/RBV in HCV Genotype 1 PI Failures
NCT01500772Phase 3Terminated
- Sponsor
- Debiopharm
- Start
- Mar 2012
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of alisporivir in hepatitis C (HCV), sponsored by Debiopharm. Started Mar 2012; status: terminated.
02
Drugs
alisporivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01500772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500772.